Posted by jtevers on December 18, 2005, at 17:03:47
In reply to NEW...OSANETANT or TALNETANT for schizophrenia, posted by jtevers on February 2, 2005, at 18:44:24
To all the hopeful:
The prospect of new and improved antipsychotics without the current horrible side effects, like weight-gain, has been diminished with the cancellation, while in phase II, of osanetant. The hope that talnetant, a similar medication being tested by glaxo-smithkline, will prove effective enough to gain phase III status remains to be seen.
Talnetant, like osanetant had been, is a neurokinin-3 antagonist currently in trials for treatment of schizophrenia. It has recently been dropped from further development for the treatment of IBS. Let's hope its prospect for the treatment of psychosis remains more promising and that in a couple of years we may have a true, new alternative for the treatment of what ails us.
The progress of talnetant within gsk's research and development portfolio could be followed at:
http://www.gsk.com/financial/pp_pipeline_standard.htmLet's cross our fingers.
John
Pennsylvania
poster:jtevers
thread:451956
URL: http://www.dr-bob.org/babble/20051211/msgs/590128.html